BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36495330)

  • 1. Gp130 is expressed in pancreatic cancer and can be targeted by the small inhibitor molecule SC144.
    Pozios I; Hering NA; Guenzler E; Arndt M; Elezkurtaj S; Knösel T; Bruns CJ; Margonis GA; Beyer K; Seeliger H
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):271-280. PubMed ID: 36495330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling.
    Pozios I; Seel NN; Hering NA; Hartmann L; Liu V; Camaj P; Müller MH; Lee LD; Bruns CJ; Kreis ME; Seeliger H
    Cell Oncol (Dordr); 2021 Feb; 44(1):167-177. PubMed ID: 32940862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a novel orally active small-molecule gp130 inhibitor for the treatment of ovarian cancer.
    Xu S; Grande F; Garofalo A; Neamati N
    Mol Cancer Ther; 2013 Jun; 12(6):937-49. PubMed ID: 23536726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Interleukin-6/Glycoprotein-130 Signaling by Raloxifene or SC144 Enhances Paclitaxel Efficacy in Pancreatic Cancer.
    Hering NA; Günzler E; Arndt M; Zibell M; Lauscher JC; Kreis ME; Beyer K; Seeliger H; Pozios I
    Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking IL-6/GP130 Signaling Inhibits Cell Viability/Proliferation, Glycolysis, and Colony Forming Activity in Human Pancreatic Cancer Cells.
    Chen X; Tian J; Su GH; Lin J
    Curr Cancer Drug Targets; 2019; 19(5):417-427. PubMed ID: 29714141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 6/gp130 axis promotes neural invasion in pancreatic cancer.
    Suzuki H; Mitsunaga S; Ikeda M; Aoyama T; Yoshizawa K; Yamaguchi M; Suzuki M; Narita M; Kawasaki T; Ochiai A
    Cancer Med; 2022 Dec; 11(24):5001-5012. PubMed ID: 35578571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines.
    Fossey SL; Bear MD; Kisseberth WC; Pennell M; London CA
    BMC Cancer; 2011 Apr; 11():125. PubMed ID: 21481226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine Oncostatin M Acts via Leukemia Inhibitory Factor Receptor to Phosphorylate Signal Transducer and Activator of Transcription 3 (STAT3) but Not STAT1, an Effect That Protects Bone Mass.
    Walker EC; Johnson RW; Hu Y; Brennan HJ; Poulton IJ; Zhang JG; Jenkins BJ; Smyth GK; Nicola NA; Sims NA
    J Biol Chem; 2016 Oct; 291(41):21703-21716. PubMed ID: 27539849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased SPON1 promotes pancreatic ductal adenocarcinoma progression by enhancing IL-6 trans-signalling.
    Huo Y; Yang J; Zheng J; Xu D; Yang M; Tao L; Yao H; Fu X; Yang J; Liu D; Hua R; Zhang J; Sun Y; Hu L; Liu W
    Cell Prolif; 2022 May; 55(5):e13237. PubMed ID: 35487760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bazedoxifene as a Novel GP130 Inhibitor for Pancreatic Cancer Therapy.
    Wu X; Cao Y; Xiao H; Li C; Lin J
    Mol Cancer Ther; 2016 Nov; 15(11):2609-2619. PubMed ID: 27535971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. gp130 Cytokines Activate Novel Signaling Pathways and Alter Bone Dissemination in ER+ Breast Cancer Cells.
    Omokehinde T; Jotte A; Johnson RW
    J Bone Miner Res; 2022 Feb; 37(2):185-201. PubMed ID: 34477239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic stellate cell secreted IL-6 stimulates STAT3 dependent invasiveness of pancreatic intraepithelial neoplasia and cancer cells.
    Nagathihalli NS; Castellanos JA; VanSaun MN; Dai X; Ambrose M; Guo Q; Xiong Y; Merchant NB
    Oncotarget; 2016 Oct; 7(40):65982-65992. PubMed ID: 27602757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation as a chemoprevention target in asbestos-induced malignant mesothelioma.
    Kadariya Y; Sementino E; Shrestha U; Gorman G; White JM; Ross EA; Clapper ML; Neamati N; Miller MS; Testa JR
    Carcinogenesis; 2022 Dec; 43(12):1137-1148. PubMed ID: 36355620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling.
    Wang Y; Ma H; Zhao C; Liu T; Yan D; Jou D; Li H; Zhang C; Lü J; Li C; Lin J; Li S; Lin L
    Oncotarget; 2017 May; 8(20):33683-33693. PubMed ID: 28430601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer.
    Nagathihalli NS; Castellanos JA; Shi C; Beesetty Y; Reyzer ML; Caprioli R; Chen X; Walsh AJ; Skala MC; Moses HL; Merchant NB
    Gastroenterology; 2015 Dec; 149(7):1932-1943.e9. PubMed ID: 26255562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
    Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP
    J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activating the interleukin-6-Gp130-STAT3 pathway ameliorates ventricular electrical stability in myocardial infarction rats by modulating neurotransmitters in the paraventricular nucleus.
    Gao M; Yin D; Chen J; Qu X
    BMC Cardiovasc Disord; 2020 Feb; 20(1):60. PubMed ID: 32024466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of the JAK/STAT pathway by LIF and OSM in the human granulosa cell line COV434.
    Pastuschek J; Poetzsch J; Morales-Prieto DM; Schleußner E; Markert UR; Georgiev G
    J Reprod Immunol; 2015 Apr; 108():48-55. PubMed ID: 25817464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
    Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of phosphorylated estrogen receptor beta is an independent negative prognostic factor for pancreatic ductal adenocarcinoma.
    Pozios I; Knösel T; Zhao Y; Assmann G; Pozios I; Müller MH; Bruns CJ; Kreis ME; Seeliger H
    J Cancer Res Clin Oncol; 2018 Oct; 144(10):1887-1897. PubMed ID: 30046904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.